Llwytho...
Decreased serum level of sphingosine‐1‐phosphate: a novel predictor of clinical severity in COVID‐19
The severity of coronavirus disease 2019 (COVID‐19) is a crucial problem in patient treatment and outcome. The aim of this study is to evaluate circulating level of sphingosine‐1‐phosphate (S1P) along with severity markers, in COVID‐19 patients. One hundred eleven COVID‐19 patients and forty‐seven h...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | EMBO Mol Med |
|---|---|
| Prif Awduron: | , , , , , , , , , , , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
John Wiley and Sons Inc.
2020
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7744841/ https://ncbi.nlm.nih.gov/pubmed/33190411 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15252/emmm.202013424 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|